HUBBARD, Ohio--(BUSINESS WIRE)--NanoLogix (OTC MARKETS: NNLX), a biotechnology innovator in the rapid detection and identification of live-cell bacteria and microorganisms, announced today its latest innovation for the microbial diagnostic industry, the Flat Pack. The company has applied for a patent for this new packaging method to improve on conventional Petri packaging practices. The Flat Pack method more effectively protects the quality and integrity of NanoLogix BioNanoPore (BNP) and BioNanoFilter (BNF) Rapid Test Kits during both shipment and long-term storage, for all types of laboratory settings and locations.
